C.D.C. Quietly Appoints Doctor Known for Vaccine Skepticism as Deputy Director

Background

During the height of the COVID‑19 pandemic, Dr. Ralph Lee Abraham garnered national attention for endorsing treatments that have been widely discredited by the scientific community, such as ivermectin. At the time, he served as Louisiana’s surgeon general, where he controversially paused the state’s mass vaccination effort.

New Appointment

In a move that has raised eyebrows among public‑health experts, the Centers for Disease Control and Prevention (C.D.C.) announced the appointment of Dr. Abraham as its second‑in‑command. The decision was made without a public press briefing, and the agency has provided only a brief statement confirming the appointment.

Reactions

Health officials and medical societies have expressed concern over the choice, noting Dr. Abraham’s history of promoting unproven therapies and questioning his alignment with evidence‑based public‑health policy. “The C.D.C. has a responsibility to uphold scientific integrity,” said one leading epidemiologist. “This appointment could undermine public confidence in vaccination programs.”

Potential Impact

Critics fear that Dr. Abraham’s influence could shift the agency’s stance on vaccine outreach and pandemic preparedness. Supporters, however, argue that his “outside‑the‑box” approach might bring fresh perspectives to a bureaucracy they view as overly cautious.

What Comes Next?

The C.D.C. has not detailed Dr. Abraham’s specific responsibilities, but observers expect him to be involved in strategic planning for future disease‑control initiatives. As the agency navigates the post‑pandemic landscape, the appointment will likely remain a focal point of debate among policymakers, healthcare professionals, and the public.